Cargando…
The concentration of desmethylmisonidazole in human tumours and in cerebrospinal fluid.
The concentration of desmethylmisonidazole (DESMISO) was determined in 60 biopsy samples taken from 13 human tumours and in cerebrospinal fluid (CSF) from 8 patients after oral administration. In comparison with misonidazole (MISO), peak concentrations in plasma were reached at earlier times and hal...
Autores principales: | Dische, S., Saunders, M. I., Riley, P. J., Hauck, J., Bennett, M. H., Stratford, M. R., Minchinton, A. I. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1981
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010594/ https://www.ncbi.nlm.nih.gov/pubmed/7225285 |
Ejemplares similares
-
Pharmacokinetic and tumour-penetration properties of the hypoxic cell radiosensitizer desmethylmisonidazole (Ro 05-9963) in dogs
por: White, R. A. S., et al.
Publicado: (1980) -
A drug for improved radiosensitization in radiotherapy.
por: Dische, S., et al.
Publicado: (1980) -
The radiosensitizer Ro 03-8799 and the concentrations which may be achieved in human tumours: a preliminary study.
por: Saunders, M. I., et al.
Publicado: (1982) -
Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry.
por: Wilson, G. D., et al.
Publicado: (1988) -
Continuous, hyperfractionated, accelerated radiotherapy (CHART).
por: Dische, S., et al.
Publicado: (1989)